Further, the pooling analysis results of the Oncomine database (Additional file 3: Figure S3) verified that compared to normal controls, the expression of DLGAP5 was significantly higher in colorectal cancer, sarcoma cancer, breast cancer and lung cancer (all P < 0.05) tissues. The gene discussed is DLGAP5; the disease is lung cancer.